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Abstract: I nt roduc t ion: Uterine leiomyoma is the most widespread benign tumor aff ecting women 
of childbearing age. Th ere are still gaps in the understanding of its pathogenesiss. Telocytes are unique 
cells described in greater than 50 diff erent locations inside the human body. Th e functional relation-
ship of cells could clarify the pathogenesis of leiomyomata. In the current study, we focused on the 
identifi cation of telocytes in all regions of the human uterus to explain their involvement in leiomyoma 
development.
Mater ia l s  a nd Met hod s: Tissue samples from a healthy and myomatous uterus were stained for c-kit, 
tryptase, CD34 and PDGFRα to identify telocytes. Routine histology was performed to analyze tissue 
morphology and collagen deposits.
Re su l t s: Telocytes were detected in the cervix, corpus of the uterus and leiomyoma. Th e density of 
telocytes in fi broid foci was reduced compared with normal myometrium.
C onc lu s ion s: Our results demonstrated the existence of telocytes in all parts of the human body 
aff ected and unaff ected by leiomyoma of the uterus. In addition, telocytes were also present in leio-
myoma foci. Our results suggest that the reduced density of telocytes is important for the patho-
mechanisms of myometrial growth, demonstrating its value as a main component of the myomatous 
architecture. 
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Introduction
Th e uterus is a  unique myometrial organ that undergoes structural and functional 
remodeling. Successful implantation plays a  crucial role in female reproductive 
processes. Rich vascularization, a  network of autonomic innervation, sensitivity 
to hormonal regulation, and fl uctuation in growth factors and cytokines, forms 
a  physiological background of myometrial tissue contractility and growth. 
Unfortunately, the human uterus is commonly affected by leiomyomas and 
adenomyosis in childbearing age that lead to severe medical and social problems, 
such as infertility [1].
The most widespread benign monoclonal tumor of the female reproductive 
system is uterine leiomyoma (UL) originating from the Müllerian duct [2–4]. 
Despite a  long history of discovery even in the time of Hypocrates and numerous 
explanations for thousands of years, the nature of fi broids is still not well understood 
[3]. Uterine fi broids exhibit heterogeneous cellular phenotypes but are consistently 
characterized by excessive production of extracellular matrix (ECM) that abnormally 
forms in fi broid foci [5–8]. Th e ECM consists of fi broblasts that are oft en termed 
myofi broblasts [9]. Th ese cells produce collagen and other components of the matrix, 
but their inappropriate function causes fi brosis [10]. Most collagen deposits include 
type I  [5] and type III collagen [11]. A similar trend is noted for the expression of 
its messenger ribonucleic acid (mRNA) [12]. Clear detailed observations of cell-cell 
interactions inside fi broids and adjacent myometrium reveal the pathomechanisms of 
ECM composition.
For the past twenty years, the scientifi c community has been intently discussing 
a new type of cells — interstitial Cajal-like cells (ICLC), which are also referred to as 
fi broblast-like cells or PDGFRα-positive cells. Since 2010, these cells have been identifi ed 
as telocytes (TCs) in nomenclature with unique features of identifi cation  [13–15]. 
TCs exhibit an oval-shaped body with several long extensions, called telopodes, 
which represent a  cell form and exhibit variability in homo and heterocellular 
contacts [16, 17]. Th eir thick and thin parts (podoms and podomers, respectively) are 
variable in size in pregnant and nonpregnant myometrium (Table 1) [13, 15, 18–21]. 
TCs are completely diff erent from fi broblasts and mesenchymal stem cells in 
a  variety of features, including phenotype. Th eir gene profi le contains thousands of 
up- and downregulated genes compared with other cells. Some of these genes are 
involved in tissue remodeling. Collagen type IV is upregulated in cultured TCs [22]. 
Th ese cells were described in several diseases [23–25]. Systematic sclerosis (SSc) 
was accompanied by ultrastructural alterations (swollen mitochondria, cytoplasmic 
vacuolization and presence of lipofuscinic bodies) of TCs that are reduced in the 
skin, correlating with disease subsets and stages. Moreover, the same changes were 
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described in the gastric wall (submucosa and muscle layers), the myocardium and 
the lung [26]. Manetti et al. observed limited and diff use cutaneous SSc in early and 
advanced stages and concluded that the damage and loss of TCs might be caused by 
an ischemic injury as TCs appear to be more sensitive to ischemia compared with 
other stromal cell types, such as fibroblasts, myofibroblasts and mast cells [27]. 
A  reduction in TCs in organs affected by SSc might be a  cause of uncontrolled 
fi broblast/myofi broblast activity [26, 27].





Length of telopodes (Tps) Normal Longer
Podomers of telocytes Th inner (75.53 ± 1.81 nm) Th icker (81.94 ± 1.77 nm)
Podoms of telocytes Th icker (316.38 ± 17.56 nm) Th inner (268.60 ± 8.27 nm)
Evidence of exosomes/shedding 
microvesicles (SMVs) Normal Lower
Diameter of extracellular vesicles 
measured in the myometrial 
interstitium
58–405 nm 65–362 nm
*Median value 151 nm 170 nm
Exosomes: SMVs 20 vs. 168 26 vs. 89
Mean diameter of exosomes/SMVs No diff erence No diff erence
Th e aim of our study was to determine the location of TCs in diff erent parts of 
the human uterus (exo- and endocervix, corpus and focus of fi broid) and to clarify 
their possible role in the architecture of leiomyomata.
Material and Methods
Subjects
Nineteen patients with symptomatic UL were scheduled for elective surgery 
(laparoscopic hysterectomy) and selected for the study group (19 women, mean age 
59.5 ± 14.6 years). Patients with UL exhibited detectable tumors in the uterus during 
gynecological examination before the operation. Th ey presented with mild, recurrent 
episodes of vaginal bleeding and pain. Th e control group consisted of 15 patients 
(15 women, mean age 57.6 ± 12.8 years) who underwent elective surgery for other 
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reasons and had no pre- or intraoperative signs of uterine fi broids. Hysterectomy was 
performed according to the standard procedure. Postsurgery histological examination 
did not reveal any signs of UL. Tissue samples from the foci of fi brosis and adjacent 
myometrium were obtained from the study group for further observation. Samples of 
unaff ected myometrium were also prepared from the control group. All patients were 
surgically treated at the Institute of Gynecology and Obstetrics at the Jagiellonian 
University Medical College in 2018.
Ethical approval
Th e study was conducted in accordance with the moral, ethical, regulatory and 
scientifi c principles governing clinical research. All surgical samples were retrieved 
with the approval of the Jagiellonian University Bioethical Committee using 
procedures that conformed to the Declaration of Helsinki guidelines (protocol 
number 122.6120.40.2016).
Tissue processing
Fresh hysterectomy specimens were collected and rinsed thoroughly with PBS 
(phosphate-buff ered saline, 0.01 M, pH = 7.4), fi xed in 4% phosphate-buff ered 
paraformaldehyde, and routinely processed and embedded in paraffi  n. Serial sections 
were cut and mounted on poly-L-lysine-coated glass slides. 
Routine histology
Th e sections were deparaffi  nized, rehydrated and stained with either hematoxylin–
eosin (H&E) to evaluate the gross tissue organization or Masson trichrome staining to 
detect collagen deposits.
Immunofl uorescence
Indirect double immunofluorescence after heat-induced epitope retrieval was 
used for simultaneous visualization of two antigens. Aft er deparaffi  nization and 
rehydration, the slides were incubated for 30 min in PBS with appropriate normal 
serum at room temperature followed by overnight incubation at 4°C in a  solution 
of PBS with appropriate normal serum containing primary antibody (or mixture of 
primary antibodies) and 0.3% Triton X-100 (Sigma, USA). Aft er 5 washes (10  min 
each) in PBS, the specimens were then incubated for 1 h at room temperature 
with secondary antibody (or mixture of secondary antibodies) diluted in PBS. 
Finally, the slides were washed twice in PBS (10 min each) and cover-slipped 
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with Fluorescence Mounting Medium (Dako, Denmark). Labeled specimens were 
analyzed immediately. Th e primary antisera and secondary antibodies used are listed 
in Table 2.
Table 2. Type, sources and dilution of antibodies.
Antibody Catalog number and company Dilution
Primary antibodies
Polyclonal rabbit anti-c-kit A4502, Dako 1 : 100
Monoclonal mouse anti-CD34 M7165, Dako 1 : 100
Polyclonal goat anti-PDGFR alpha AF-307-NA, R&D Systems 1 : 100
Monoclonal Mouse anti-tryptase M7052, Dako 1 : 100
Secondary antibodies
Alexa Fluor 488 Goat Anti-Mouse 115-545-146, Jackson ImmunoResearch 1 : 400
Alexa Fluor 594 Goat Anti-Rabbit 111-585-144, Jackson ImmunoResearch 1 : 400
Alexa Fluor 594 Donkey Anti-Goat 705-585-003, Jackson ImmunoResearch 1 : 400
Alexa Fluor 488 Rabbit Anti-Mouse 315-545-045, Jackson ImmunoResearch 1 : 400
Microscopic examination
Slides were examined using an MN800FL epifl uorescence microscope (OptaTech, 
Warszawa, Poland) equipped with a  Jenoptik Progress C15Plus color camera. Digital 
images were collected at either 200× or 400× magnifi cation. Qualitative analysis of 
cells was provided in 10 consecutive high-power fi elds of vision (400×) using the 
computer-based image analysis system Multiscan 18.03 soft ware (CSS, Warszawa, 
Poland). All samples were assessed by two independent specialists (each blinded 
to the other) without any knowledge of the clinical parameters or other prognostic 
factors to avoid bias. Th e use of mast cell tryptase staining enabled c-kit-positive mast 
cells to be distinguished from c-kit-positive TCs. TCs were considered cells that were 
c-kit positive and tryptase negative concurrently with the characteristic morphology 
in tissue samples. Additionally, cells double positive for CD34 and PDGFRα with 
characteristic morphology and localization were also recognized as TCs. In all 
sections, the immunoreactive cells identifi ed were evaluated with respect to the relative 
frequency (arbitrarily graded as very few = (+), few = +, moderate density = + +, 
multiply density = + + +). Th e percentage of collagen deposits and muscle tissue were 
analyzed in specimens stained with Masson trichrome. Th e collagen and muscle fi ber 
volume ratio was assessed in ten diff erent fi elds of each sample. 
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Results
Th e histopathological observation of the human myomatous and unaff ected uterus 
using hematoxylin and eosin and Masson’s trichrome staining was performed 
(Fig.  1,  2). Corpus of myomatous uterus presented as foci of UL and adjacent 
myometrium. Immunofl uorescent labeling was also used for all samples: the corpus 
and uterine cervix (exo- and endocervix) as well as leiomyoma foci. We assessed 
Fig. 1. Hematoxylin-eosin and Masson’s trichrome stained sections of human uterus unaff ected by 
leiomyoma. Th e sections from exocervix (A, D) endocervix (B, E) and myometrium from the uterus body 
(C, F). On Masson’s trichrome staining, collagen deposits appear as blue, and muscle fi bers appear as red. 
Total magnifi cation: 200×.
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Fig. 2. Hematoxylin-eosin and Masson’s trichrome stained sections of human myomatous uterus. Sections 
from the exocervix (A, E) endocervix (B, F), leiomyoma foci (D, H) and adjacent myometrium from the 
same uterus (C, G). On Masson’s trichrome staining, collagen deposits appear as blue, and muscle fi bers 
appear as red. Fragments of disordered smooth-muscle cells separated by abundant extracellular matrix 
(ECM). Total magnifi cation: 200×.
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mostly currently proven markers: CD34, PDGFRα and canonic c-kit (Fig. 3, 4). Double 
immunolabeling for c-kit and tryptase was used for the identifi cation of mast cells 
and subsequent signs of infl ammation. Th e c-kit-positive/mast cell tryptase-negative 
cells were considered TCs. CD34-positive and PDGFRα-positive cells were detected as 
uterine TCs.
Fig. 3. Sample from the a leiomyoma focus stained for c-kit (red, Alexa Fluor 594). Total magnifi cation: 400×.
Fig. 4. Sample from a leiomyoma focus stained for CD34 (green, Alexa Fluor 488). Total magnifi cation: 400×.
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Hematoxylin and eosin staining demonstrated than UL were mainly composed 
of smooth muscle cells and fi brous connective tissue. Smooth muscle cells exhibited 
a uniform spindle size and shape with rhabditiform nuclei. Th e adjacent myometrium 
and fi broid foci were cytologically identical, but the latter exhibited circumscription, 
nodularity and denser cellularity. Masson’s trichrome staining revealed the prevalence 
of collagen deposits in UL compared with all other observed samples. 
We found that cells with the characteristic morphology and immunopositivity 
were located in all parts of the human uterus. Th ese cells exhibit a triangular or spindle 
body with long, slender, moniliform cytoplasmic extensions. Th e endocervix contains 
more c-kit-positive, CD34-positive and PDGFRα-immunopositive cells compared 
with the exocervix. Th ese cells formed bundles mainly located longitudinally (parallel 
to the cervical canal). No diff erences in TC density were noted in all parts of the 
uterine cervix between myomatous and healthy uteruse.
In the corpus of the uterus, TCs were located in close vicinity to blood vessels 
and inside muscle bundles. The general pattern of their localization resembled 
parallel eccentric lines in UL. We stressed that CD34-immunopositive and 
PDGFRα-immunopositive cells were observed in leiomyoma foci as well as 
in adjacent and control myometrium (Fig. 5). In all sections, immunoreactive 
cells were evaluated with respect to the relative frequency (arbitrarily graded 
as very few = (+), few = +, moderate density = + +, multiply density = + + +) 
(Table 3). Subjective qualitative analyses exhibited a  reduction in TC density in 
fi broids compare with both types of unaff ected myometrium (adjacent and from 
healthy uterus). 
Table 3. Relative frequency of c-kit-positive/tryptase-negative, CD34-positive and PRGFRα-positive 
cells in diff erent parts of human uterus that was not aff ected or aff ected by leiomyoma. 0 = absence of 
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Fig. 5. Uterine samples stained for PDGFRα (red, Alexa Fluor 594) from uterus unaff ected by 
leiomyoma myometrium (A) and fi broid focus (B). Telocytes with their longitudinal extensions are 
mostly located among the intertwined myometrial fi bers and in close vicinity to blood vessels. Total 
magnifi cation: 400×.
Discussion
Th is study presents evidence for the presence of TCs in diff erent parts of the uterus, 
including exocervix, endocervix, and corpus in human healthy uterus, as well 
as fi broid foci in myomatous uterus. Identifi cation was based on morphological 
and immunocytochemical criteria in fl uorescence microscopy. We assumed that 
CD34- and PDGFRα-positive cells are TCs. In addition, c-kit-positive cells and 
trypatase-negative cells were also recognized as TCs.
Homo and heterocellular contacts between TCs and smooth muscle cells, nerves, 
immunocytes (macrophages, mast cells and lymphocytes), stem cells, melanocytes, 
erythrocytes and Schwann cells highlight their involvement in creating of 3D structure 
of tissue and facilitating muscle contractions and immune responses. Th e crucial role 
of these cells in the physiology and pathophysiology of organs has been described and 
hypothetically focused on their involvement in pathomechanisms of various diseases. 
Uterine TCs could represent a key cell type in the uterine leiomyoma that exhibits its 
own architecture despite its monoclonal origin [28–30]. 
Th e main feature of each uterine fi broid is excessive production of ECM that 
could play a  role in the storage of cytokines, chemokines, growth factors, angio-
genic and infl ammatory response mediators that subsequently stimulate cell growth 
and diff erentiation [9]. Uterine smooth muscle cells and fi broblasts produce several 
growth factors that are present in different amounts in fibroids and adjacent 
myometrium. The ECM of leiomyomas demonstrates the focal localization of 
basic fi broblast growth factor (FGF)-2 and insulin-like growth factor (IGF)-I. Th e 
amount of epidermal growth factor (EGF) is signifi cantly reduced in UL compared 
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with normal myometrium. Dixon et al. illustrated a hormonal regulation of growth 
factor production based on the suggestion that EGF secretion could be regulated by 
progesterone (and not estrogen) [31].
Richter et al. assessed the correlation between collagen type I  deposits and 
TC distribution in heart muscle [32]. Fibroblasts produced collagen type I  upon 
stimulation by growth factors. In the normal human heart, TCs were identified 
in close vicinity to thin collagen fi brils. In contrast, in heart failure, some parts of 
myocardium have been replaced by focuses of fi brosis that are grossly characterized 
by excessive amounts of type I  collagen. In these areas of the heart, no TCs were 
identified. Zhao et al. stressed that TCs in the myocardium are important for 
maintenance of the physiological integrity of heart muscle [33]. Of note, a  direct 
correlation was observed between collagen type I deposits and the presence of TCs. 
Moreover, the number of TCs and Tps was positively correlated with degraded 
collagen type I  [32]. Tps were characterized by shrinkage and shortening in areas 
of abundant ECM. We observed the same results in the myometrium by comparing 
the density of uterus TCs in fi broid foci characterized by excessive amounts of ECM 
and normal myometrium. In  UL, an increased ECM density correlates with rare 
cell observations that represent typical morphological and immunohistochemical 
features of TCs. 
Another important feature of leiomyoma is the origination of the cell population. 
Th e myometrium itself has a regenerative capacity. Ono et al. observed two groups of 
leiomyoma-derived cell populations: side and main populations. Th e fi rst population 
was undiff erentiated and rarely expressed steroid hormone receptors and smooth 
muscle cell markers. After some time, these cells naturally express all receptors 
and become similar to the main population, which is common for fi broids. Ono 
et al. stressed the importance of paracrine factor-mediated signals from steroid 
receptor-positive cells adjacent to leiomyoma-derived side population cells [34]. 
We suggest that TCs dominate among adjacent cells. TCs exhibit place-dependent 
specifi city for estrogen and progesterone receptors. TCs in the gallbladder are negative 
for both types of receptors [35] but positive in myometrium, Fallopian tubes or 
human urinary bladder [36–38]. TCs could play the role of eff ector cells in paracrine 
cooperation between steroid hormones and side population cells, as reported by the 
Ono scientifi c group [34]. We also want to emphasize that undiff erentiated cells in 
UL are an important component of fi broid cell architecture and appear to be somatic 
stem cells. 
Telocytes were detected in the stem cell niche of diff erent organs, such as the 
heart, lung, skeletal muscle, and skin [39–43]. Heterocellular contacts between these 
two types of cells explain the possible involvement of TCs in tissue regeneration 
and repair. Th e fi rst explanation of microenvironment-controlled stem cell activity, 
which is referred to as the niche, was provided 30 years ago [44]. Since that time, 
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numerous studies observed interplay between stem cell behavior and the surrounding 
tissue. Stem cells not only respond to multiple stimuli but also have an impact on 
the organism; it is therefore important to consider each stem cell interaction in both 
directions [45]. Gherghiceanu et al. focused on TC involvement in cardiac stem cell 
homeostasis [43]. Popescu et al. observed TCs-stem cells complexes in subepithelial 
niches of the bronchiolar tree [42]. Perlea et al. discussed possible detection of TCs in 
dental pulp stem niches [40], whereas Ye et al. assessed the genetic profi le of murine 
lung TCs and their functional role in the stem cell niche [41]. We hypothesized that 
the bilateral interaction between uterine TCs and stem cells could represent a step in 
the pathogenesis of leiomyoma.
Our study proved the existence of telocytes in diff erent parts of the human uterus 
(cervix, corpus, focuses of fi broids) — both aff ected and not aff ected by leiomyoma. 
Qualitative analysis revealed the reduction of TCs in fibroid foci, whereas the 
prevalence of collagen deposits was detected using routine histology. We attempted 
to explain the place of TCs in myoma architecture and focused on basic connecting 
points. We intend to continue our research to clarify the versatility of myometrial TCs 
and their fascinating properties. 
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